OVERVIEW: The Johnson & Johnson Foundation devotes its global health dollars to expanding reproductive health services for women and girls, eliminating mother-to-child transmission of HIV, and combating fistula.
IP TAKE: Unfortunately, if you want to talk Johnson & Johnson Foundation funding, you have to connect with company executives.
PROFILE: The Johnson & Johnson Family of Companies consists of some 250 companies operating all over the world and that are engaged in various facets of the health industry. Its philanthropic arm, the Johnson and Johnson Family of Companies Foundation, largely funds projects through in-kind donations, pharmaceutical subsidies (mostly in the U.S.), and cash grants. The company also offers a generous employee donation-matching program, of which many grants are awarded via the foundation.
The foundation grants associated with global health are awarded through its stated priority areas, including:
Women and children. Grants are awarded to organizations combating fistula, improving prenatal and neonatal health services, and protecting children from parasitic worms.
Preventing diseases. The foundation's disease work is almost entirely devoted to fighting mother-to-child transmission of HIV in low-income countries.
Strengthening the health-care workforce. The foundation funds nursing and midwifery training in places where the need for health services far exceeds their availability.
Johnson and Johnson’s grants typically range from $25,000 to $100,000, but makes a handful of grants over $1 million. At times, Johnson & Johnson will give multiple smaller grants to a single organization to support projects in different specialty areas.
The foundation does not accept unsolicited funding applications, and comprehensive data on its grantmaking is difficult to find. Its funding priorities are selected by teams of senior executives, and a corporate contributions committee (CCC) provides strategic guidance for foundation spending.
- Michael Sneed, President
- Sharon D’Agostino, Vice President